Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure. [PDF]
BiomoleculesBogáti R +8 more
europepmc +1 more source
Plasmin-Antiplasmin Complex as a New Predictive Marker of Postoperative Venous Thromboembolism in Patients with Gynecologic Malignancy. [PDF]
Clin Appl Thromb HemostMa J, Tang Y, Zhou J, Zhao A, Shi J.
europepmc +1 more source
STUDY OF FIBRINOLYSIN ON CLOTTED HEMOTHORAX
The Journal of Thoracic and Cardiovascular Surgery, 1964 H D, PEARSE, R M, NELSON
openaire +2 more sources
Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study. [PDF]
BMC Cardiovasc DisordFeng YF +5 more
europepmc +1 more source
Mendelian randomization reveals plasminogen as a common therapeutic target for myocardial infarction and atrial fibrillation. [PDF]
J Cardiovasc Thorac ResCharati H, Hamta A.
europepmc +1 more source
Recombinant chymase inhibits fibrinolysis induced by endogenous plasmin in clotted human blood. [PDF]
Front ImmunolVincent L +8 more
europepmc +1 more source
The time course of alpha 2-plasmin inhibitor and plasmin-alpha 2-plasmin inhibitor complex levels in patients with traumatic brain injury. [PDF]
Acta Neurochir (Wien)Kanaya T +9 more
europepmc +1 more source
Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement. [PDF]
J Am Heart AssocLiu R +9 more
europepmc +1 more source